K. Ramakrishnan Bhaskar

Author

Also Known As

K R Bhaskar, K Ramakrishnan Bhaskar, K. Bhaskar, K. R. BHASKAR, K. R. Bhaskar, K. Ramakrishnan Bhaskar, K.R. Bhaskar, K.Ramakrishnan Bhaskar, Kanna Bhaskar

Publications

3.2K

Citations

H-Index

111

Concepts

All Affiliations

Harvard University Boston University Beth Israel Deaconess Medical Center Boston Children's Hospital Boston Medical Center

About

K. Ramakrishnan Bhaskar is an author at Harvard University specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.6K
2	Natural Sciences	11	12	425
3	Engineering	6	6	683
4	Health Sciences	1	1	108
5	Public Health	1	1	53

K. Ramakrishnan Bhaskar

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
AWNN-Assisted Wind Power Forecasting Using Feed-Forward Neural Network K. Ramakrishnan Bhaskar, S. N. Singh IEEE Transactions on Sustainable Energy EngineeringWind Power GenerationData ScienceSmart GridWind Power Penetration	2012	373
Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells Ignazio Castagliuolo, J. Thomas LaMont, Bosheng Qiu, American Journal of Physiology-Gastrointestinal and Liver Physiology ImmunologyGastroenterologyCell DeathImmobilization StressMast Cell Degranulation	1996	249
Viscous fingering of HCI through gastric mucin K. Ramakrishnan Bhaskar, Peter Garik, Bradley S. Turner, Nature EngineeringFluid MechanicsGastroenterologyGastric MucinBiomedical Engineering	1992	223
pH-Dependent Conformational Change of Gastric Mucin Leads to Sol-Gel Transition Xingxiang Cao, Rama Bansil, K. Ramakrishnan Bhaskar, Biophysical Journal	1999	218
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression Stavros Sougioultzis, Simos Simeonidis, K. Ramakrishnan Bhaskar, Biochemical and Biophysical Research Communications InflammationCytokineAnti-inflammatoryMicrobial PathogensSoluble Anti-inflammatory Factor	2006	193
Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies Yury Popov, Eleonora Patsenker, Felix Stickel, Journal of Hepatology FibrosisHepatic DisordersHepatologyLiver PhysiologyPortal Liver Fibrosis	2008	180
Saccharomyces boulardii Inhibits ERK1/2 Mitogen-activated Protein Kinase Activation Both in Vitro and in Vivo and Protects against Clostridium difficile Toxin A-induced Enteritis Xinhua Chen, Efi Kokkotou, Nasima Mustafa, Journal of Biological Chemistry	2006	152
Atomic Force Microscopy Reveals Aggregation of Gastric Mucin at Low pH Zhenning Hong, B. Chasan, Rama Bansil, Biomacromolecules	2005	145
Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice Yury Popov, Deanna Sverdlov, Anisha Sharma, Gastroenterology InflammationFibrosisLiver FibrosisHepatologyTissue Transglutaminase Does	2011	140
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis Yury Popov, Deanna Sverdlov, K. Ramakrishnan Bhaskar, American Journal of Physiology-Gastrointestinal and Liver Physiology Experimental Biliary FibrosisApoptosisImmunologyPathologyCell Death	2010	135

Page 1